tiprankstipranks
Manzo Pharmaceuticals, Inc. (MNZO)
:MNZO
US Market

Manzo Pharmaceuticals (MNZO) Income Statement

Compare
0 Followers

Manzo Pharmaceuticals Income Statement

Last quarter (Q0 0), Manzo Pharmaceuticals's total revenue was $―, a decrease of ― from previous quarter. In Q0, Manzo Pharmaceuticals's net income was $-1.23M. See Manzo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 04Dec 03
Total Revenue
$ ―$ ―
Gross Profit
$ 20.97K$ 755.89K
Operating Expenses
$ ―$ ―
Depreciation and Amortization
$ ―$ ―
EBITDA
$ -2.85M$ -2.30M
Operating Income
$ -3.20M$ -3.25M
Other Income/Expenses
$ ―$ ―
Pretax Income
$ ―$ ―
Net Income
$ -4.15M$ -3.95M
Per Share Metrics
$ ―$ ―
Basic EPS
$ ―$ ―
Diluted EPS
$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Manzo Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis